Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Globus Medical, Inc. GMED continues to benefit from ... Globus is also optimistic about the recently inked deal to acquire Nevro Corporation. The acquisition of Nevro is expected to expand Globus ...

Last month, Globus Medical announced a definitive agreement to acquire Nevro Corp. in an all-cash transaction valued at approximately $250 million. The transaction enables the company to expand ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Globus Medical (GMED – Research Report). The ...

Globus Medical, Inc. (NYSE:GMED – Free Report) – Investment analysts at Zacks Research reduced their Q1 2025 earnings per share (EPS) estimates for Globus Medical in a report released on ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $97.6, a high estimate of $103.00, and a low estimate of $93.00. This upward trend ...

In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Globus Medical (GMED – Research Report), with a ...

Globus Medical, Inc. (NYSE:GMED – Free Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and ...